The report "Healthcare Data Monetization Market by Type (Direct, Indirect), Deployment (On-premise, Cloud), End User (Pharmaceutical & Biotechnology Companies, Healthcare Payers, Healthcare Providers, Medical Technology Companies), Region - Global Forecast to 2028", The global healthcare data monetization market is projected to reach USD 0.9 billion by 2028, from USD 0.4 billion in 2023, at a CAGR of 18.5% from 2023 to 2028. Factors such as exponentially increasing data volume and generation of large and complex healthcare datasets, the need to curtail escalating healthcare costs, expanding partnerships and collaborations among players, and growing investments in the adoption of EHR systems primarily drive the growth of this market. Furthermore, the rising adoption of AI in precision medicine and the growing demand for real-world evidence (RWE) would provide lucrative opportunities to solution providers.
Browse 217 market data Tables and 60 Figures spread through 292 Pages and in-depth TOC on "Healthcare Data Monetization Market by Type (Direct, Indirect), Deployment (On-premise, Cloud), End User (Pharmaceutical & Biotechnology Companies, Healthcare Payers, Healthcare Providers, Medical Technology Companies), Region - Global Forecast to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/healthcare-data-monetization-market-56622234.html
The cloud segment is expected to be the fastest-growing healthcare data monetization market, by deployment, during the forecast period.
Based on deployment, the market is segmented into on-premise and cloud. The cloud segment is expected to grow at a higher CAGR during the forecast period due to increased agility and scalability offered by cloud-based data monetization solutions. Cloud platforms provide secure and scalable storage solutions for vast amounts of healthcare data, including electronic health records, medical images, and patient-generated data. Furthermore, cloud-based analytics tools enable healthcare organizations to perform advanced data analysis, leveraging machine learning algorithms and artificial intelligence to gain valuable insights from complex datasets.
The pharmaceutical & biotechnology companies segment, by end-user, is expected to be the largest healthcare data monetization market in 2023
Based on the end user, the market is broadly segmented into pharmaceutical & biotechnology companies; healthcare payers; healthcare providers; medical technology companies; and other end users. Pharmaceutical & biotechnology companies would account for the largest share of the global end-user market in 2023. Market growth can be attributed to the rising demand for solutions to cut the time and costs of drug development. Pharmaceutical and biotechnology companies can benefit significantly from healthcare data monetization, as it can help them develop new drugs, identify potential markets, and improve patient outcomes.
Asia Pacific is expected to be the fastest-growing in healthcare data monetization market during the forecast period.
The global market has been segmented based on region: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Asia Pacific market is projected to register the highest CAGR during the forecast period. Emerging countries in the Asia Pacific, such as India and China, offer lucrative growth opportunities for market players, primarily due to the increasing adoption of digital healthcare technologies, increasing public and private funding, improving IT infrastructure, the demand for affordable healthcare, favorable government norms, growing awareness about precision medicine, and the high incidence of cancer and chronic diseases are expected to boost the adoption of healthcare data monetization solutions in Asia Pacific.
Major players operating in the healthcare data monetization market are Oracle Corporation (US), Microsoft Corporation (US), Google (US), Salesforce, Inc. (US), SAS Institute Inc. (US), SAP SE (Germany), TIBCO Software Inc. (US), Sisense Inc. (US), Snowflake Inc. (US), QlikTech International AB (US), HealthVerity, Inc. (US), Accenture (Ireland), Availity, LLC (US), Domo, Inc. (US), Komodo Health, Inc. (US), ThoughtSpot Inc. (US), Datavant (US), Verato (US), Infor, Inc. (US), Virtusa (US), Infosys (India), Particle Health, Inc. (US), Innovaccer, Inc. (US), H1 (US), and Medoble Inc. (US).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441